<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Brakke Consulting&#x306E;&#x30A6;&#x30A7;&#x30D6;&#x30B5;&#x30A4;&#x30C8;</provider_name><provider_url>https://brakkeconsulting.com/ja</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="SclFsxwrYI"&gt;&lt;a href="https://brakkeconsulting.com/ja/20037/"&gt;2003 &#x5E74; 12 &#x6708; 5 &#x65E5;&#x306E;&#x52D5;&#x7269;&#x5065;&#x5EB7;&#x30CB;&#x30E5;&#x30FC;&#x30B9;&#x3068;&#x30CE;&#x30FC;&#x30C8;&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/ja/20037/embed/#?secret=SclFsxwrYI" width="600" height="338" title="&#x201C;&#x300C;2003&#x5E74;12&#x6708;5&#x65E5;&#x306E;&#x52D5;&#x7269;&#x885B;&#x751F;&#x30CB;&#x30E5;&#x30FC;&#x30B9;&#x3068;&#x30CE;&#x30FC;&#x30C8;&#x300D;&#x2014; Brakke Consulting&#x30A6;&#x30A7;&#x30D6;&#x30B5;&#x30A4;&#x30C8;" data-secret="SclFsxwrYI" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>******************************************************************* &nbsp;Brakke Consulting&rsquo;s &nbsp;Animal Health News &amp; Notes for December 5, 2003 &nbsp;Copyright &copy; Brakke Consulting, Inc. ******************************************************************* IN THE NEWS: &nbsp; earnings: Bioniche Dainippon Del Monte &nbsp; other news: Animix LLC AVI BioPharma Banfield Bioniche Butler ConAgra Degussa Eklin Medical Systems Embrex eMerge Interactive Ferno Veterinary Systems Fort Dodge Hartz Mountain Iowa Premium Pork Nestle Purina Newsham Genetics Pennexx Foods Pfizer Smithfield &nbsp; ******************************************************************** COMPANY EARNINGS RELEASES &nbsp; &gt;&nbsp; Dainippon Pharmaceuticals reported that sales of its animal science division for the first half of 2003 ended September 30, 2003 increased by 11.2% to&nbsp; 30,818 million yen ($275 million) compared with the prior-year period. This increase is mainly due to the acquisition of the animal health business of Tanabe Seiyaku in November 2002. (company news) &nbsp; &gt;&nbsp; Del Monte Foods Company reported lower Pet Products sales for the second quarter ended October 26, 2003.&nbsp; The lower sales reflected the continued anticipated reduction in sales of the non-core portions of the Pet Products portfolio and the impact of a price increase on 9Lives cat food. (Business Wire)&nbsp;&nbsp; &nbsp; &gt;&nbsp; Bioniche Life Sciences Inc. announced financial results for the first quarter ended September 30, 2003. Animal Health product sales during the first quarter were $5.6 million, a decrease of $0.4 million, or 7%, from the same period last year. This decrease isView Full Post;</description></oembed>
